CClinicalTrials.gg
RecruitingNCT05191264Updated Mar 18, 2025

Combination of Percutaneous Screw Fixation and Cementoplasty for Lytic Bone Metastases

An observational study in Interventional Radiology, sponsored by Centre Hospitalier Universitaire de Saint Etienne. Recruiting at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-03-18.

Sponsored by Centre Hospitalier Universitaire de Saint Etienne · Observational

From the registry’s dates

  • Primary completion was expected by Jun 2026, 4 months ago, but the record still lists the study as recruiting.
  • Started Jul 2019; still recruiting 7 years 2 months later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
150
Ages
18 Years and older
Sex
All
01

Study summary

In oncology, therapeutic progress has allowed a significant increase in life-expectancy: a growing number of cancer survivors live to more advanced metastatic stages. Consequently, the prevalence of secondary bone lesions is increasing, which are frequent and disabling. They are responsible for pain and a high risk of pathological fractures. The average prevalence of pain in cancer represents 53% for all stages combined and 64% for metastatic stages.

Analgesics, radiotherapy and surgery are widely used in this context, but are not without side effects.

Cementoplasty is an interventional radiology procedure that has improved the palliative management of bone lesions. It consists of a percutaneous injection of polymethylmethacrylate-based cement, whose physical and chemical properties provide resistance to compressive stress during weight-bearing activities. However, one of the main disadvantages of cement is its low resistance to torsional stress, as evidenced notably in vitro tests. Thus, cementoplasty alone is very effective at the spinal level (compressive forces) to reduce pain and risk of fracture, but much less effective at the level of other bones that are subjected to torsional stresses, notably the pelvis and femur (40% fracture rate at one year after cementoplasty alone of femoral metastasis).

Fixation using a combination of metal screws and cement provides resistance to torsional and compressive stress. In addition, it has been shown that there is a significant risk of secondary screw displacement if screws are not combined with cement in secondary bone lesions. Combination of percutaneous screw fixation and cementoplasty is a mini-invasive procedure which allows limiting complications and the duration of treatment: early standing up, almost no blood loss, reduced risk of venous thromboembolism (VTE), rapid healing.

Read the detailed description

The aim of this prospective study is to evaluate feasibility, safety, and efficacy of combination of percutaneous screw fixation and cementoplasty for lytic bone metastases.

02

Conditions studied

  • Interventional Radiology

Browse trials for

Keywords

  • Screw fixation
  • cementoplasty
  • interventional radiology
  • pain management
03

In context

Neoplasm Metastasis

3,517 studies on the registry are indexed under Neoplasm Metastasis; 885 are open to participants now.

This study's planned enrollment of 150 is above the median of 121 across 594 observational studies indexed under Neoplasm Metastasis.

Browse Neoplasm Metastasis studies →

Lead sponsor

Centre Hospitalier Universitaire de Saint Etienne is the lead sponsor of 578 studies on the registry; 128 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patient with percutaneous osteosynthesis and cementoplasty procedure will be included.

Inclusion criteria

  • patients who received osteosynthesis/cementoplasty for Lytic Bone Metastases

Exclusion criteria

Exclusion Criteria:

  • patient's refusal to participate
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
150 participants (estimated)
Patient registry
No

Groups and cohorts

  • percutaneous osteosynthesis and cementoplasty procedure

    Patient with percutaneous osteosynthesis and cementoplasty procedure will be included. Patients have assessed for pain and quality of life during consultations as part of an interventional radiology procedure (pre-procedure consultation, and follow-up consultations at 1, 3, 6 and 12 months after the procedure.

    Other: EQ5D (EuroQol 5 Dimensions) · Other: Numerical Rating Scale (NRS) · Other: evaluated the consumption of analgesics

Interventions

  • OtherEQ5D (EuroQol 5 Dimensions)

    The evaluation of the quality of life was conducted with the EQ5D (EuroQol 5 Dimensions) score (min 0: bad health and max:100 good health).

    Also known as: evaluation of the quality of life

  • OtherNumerical Rating Scale (NRS)

    the type and intensity of pain will be evaluated by Numerical Rating Scale (NRS) from 0 to 10 in different positions and in different activities (e.g. background pain, general maximum/minimum pain, pain of the site treated by the procedure, pain at rest, in lying position, in sitting position, in standing position, at bearing weight, in walking, description of painful irradiations, nocturnal awakenings).

    Also known as: evaluation of the type and intensity of pain

  • Otherevaluated the consumption of analgesics

    the consumption of analgesics by step and by dosage will be evaluated.

06

What researchers measure

Primary outcomes

  1. Technical feasibility of the procedure (Yes or No)

    The technical success of the procedure is defined as (all criteria have to be fulfilled) : * the correct placement of the screw(s), * any complication as major cement leakage such as intra-articular or intra-vascular leakage, abundant bleeding, vascular or nervous lesion, displacement of bone fragment Theses criteria are measured on CT-scan

    Time frame: Just after the end of the procedure

Secondary outcomes

  1. Adverse events

    To confirm the safety of the procedure, all adverse events related to the procedure are screened and reported

    Time frame: Months: 1, 3, 6 and 12

  2. Numerical Rating Scale

    Numerical Rating Scale (NRS) evaluates the pain. This scale starts from 0 (no pain) to 10 (maximal pain)

    Time frame: Months: 1, 3, 6 and 12

  3. EuroQol 5 Dimensions (EQ5D)

    EQ5D evaluates the quality of life.. Patients are asked to describe their own health and also provide a self-rating on a 20-cm vertical scale with endpoints of 'best imaginable health state' set at 100 and 'worst imaginable health state' set at 0

    Time frame: Months: 1, 3, 6 and 12

  4. Consumption of opioids (mg/day)

    Time frame: Months: 1, 3, 6 and 12

07

Study locations

1 of 1 sites recruiting
  • CHU Saint-Etienne
    Saint-Étienne, France
    • Sylvain GRANGE, MD · Principal investigator
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 18, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05191264
Lead sponsor
Centre Hospitalier Universitaire de Saint Etienne
Responsible party
Sponsor
First posted
Jan 13, 2022
Start date
Jul 10, 2019
Primary completion
Jun 2026 (estimated)
Completion
Jun 2026 (estimated)
Last update
Mar 18, 2025

Study contacts

Sylvain GRANGE, MD
Contact
Sylvain.Grange@chu-st-etienne.fr
(0)477829066 ext. +33
Sylvain BERTHOLON, resident
Contact
Sylvain.Grange@chu-st-etienne.fr
(0)477829066 ext. +33
Sylvain GRANGE, MD
principal investigator · CHU SAINT-ETIENNE

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion